LION's FY25 results confirm debt rollover success, with equity ratio up to 36.7%. Critical inflection point reached with NMC+ ramp-up and BESS sales acceleration anticipated. in our view. BUY, PT € 3.20.
26 Jun 2026
FY25: Significant progress on balance sheet de-risking
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
FY25: Significant progress on balance sheet de-risking
LION's FY25 results confirm debt rollover success, with equity ratio up to 36.7%. Critical inflection point reached with NMC+ ramp-up and BESS sales acceleration anticipated. in our view. BUY, PT € 3.20.